|  | EBV status < 6 months | EBV status ≥ 6-12months | ||||
---|---|---|---|---|---|---|---|
Gene mutation type | n | OR | 95% CI | P-value | OR | 95% CI | P-value |
α- thalassemia | |||||||
αα/αα | 46 | Ref | - | - | Ref | - | - |
-α3.7/αα | 34 | 1.824 | 0.511–6.512 | 0.354 | 0.681 | 0.256–1.812 | 0.442 |
Sickle cell Status | |||||||
Hb AA | 62 | Ref | - | - | Ref | - | - |
Hb AS | 17 | 0.897 | 0.217–3.708 | 0.881 | 0.513 | 0.143–1.836 | 0.305 |
G6PD Group A1 | |||||||
871G > A/1024C > T-Negative | 10 | Ref | - | - | Ref | - | - |
871G > A/1024C > T-Positive | 71 | 2.614 | 0.578–11.820 | 0.212 | 0.640 | 0.079–5.205 | 0.677 |
G6PD group A2 | |||||||
487G > A/592C > T-Negative | 4 | Ref | - | - | Ref | - | - |
487G > A/592C > T-Positive | 77 | 0.000 | 0.000 | 0.999 | 0.948 | 0.240–3.755 | 0.940 |
G6PD group B | |||||||
1360C > T /1388G > A-Negative | 15 | Ref | - | - | Ref | - | - |
1360C > T /1388G > A-Positive | 66 | 0.321 | 0.038–2.686 | 0.295 | 1.221 | 0.325–4.592 | 0.768 |
G6PD African A- | |||||||
B | 6 | Ref | - | - | Ref | - | - |
A- | 19 | xx | xx | 1.000 | 0.000 | 0.000 | 0.235 |
A | 55 | xx | xx | 0.999 | 0.278 | 0.030–2.544 | 0.257 |
B and A | 61 | Ref | - | - | Ref | Â | Â |
A- | 19 | 0.281 | 0.081–0.978 | 0.046 | 0.223 | 0.153–1.549 | 0.487 |
MSP-2 | |||||||
FC27 Negative | 50 | Ref | - | - | Ref | - | - |
FC27 Positive | 20 | 0.922 | 0.213–3.990 | 0.914 | 0.780 | 0.256–2.373 | 0.662 |
3D7 Negative | 29 | Ref | - | - | Ref | - | - |
3D7 Positive | 41 | 0.933 | 0.238–3.656 | 0.921 | 0.549 | 0.201–1.496 | 0.241 |